Aytu BioPharma, Inc. (AYTU) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 12.41M | 15.16M | 13.89M | 15.13M | 18.45M | 16.22M | 16.57M | 17.98M | 14.03M | 18.75M | 17.82M | 30.73M | 22.73M | 26.28M | 27.66M | 27.45M | 24.2M | 23.13M | 21.9M | 23.48M |
| Revenue Growth % | -32.74% | -6.51% | -16.21% | -15.8% | 31.57% | -13.48% | -6.98% | -41.51% | -38.31% | -28.66% | -35.57% | 11.96% | -6.06% | 13.64% | 26.3% | 16.89% | 79.48% | 52.67% | 61.96% | 58.01% |
| Cost of Goods Sold | 5.57M | 6.07M | 4.7M | 4.88M | 5.65M | 5.43M | 4.59M | 6.07M | 3.66M | 4.14M | 4.78M | 12.17M | 9.99M | 8.99M | 9.62M | 14.61M | 11.51M | 10.83M | 9.44M | 12.18M |
| COGS % of Revenue | 44.9% | 40.01% | 33.86% | 32.25% | 30.6% | 33.51% | 27.69% | 33.77% | 26.12% | 22.11% | 26.82% | 39.59% | 43.94% | 34.19% | 34.8% | 53.21% | 47.58% | 46.82% | 43.12% | 51.88% |
| Gross Profit | 6.84M | 9.1M | 9.19M | 10.25M | 12.81M | 10.79M | 11.98M | 11.91M | 10.36M | 14.6M | 13.04M | 18.56M | 12.74M | 17.29M | 18.03M | 12.84M | 12.69M | 12.3M | 12.46M | 11.3M |
| Gross Margin % | 55.1% | 59.99% | 66.14% | 67.75% | 69.4% | 66.49% | 72.31% | 66.23% | 73.88% | 77.89% | 73.18% | 60.41% | 56.06% | 65.81% | 65.2% | 46.79% | 52.42% | 53.18% | 56.88% | 48.12% |
| Gross Profit Growth % | -46.6% | -15.65% | -23.35% | -13.88% | 23.6% | -26.14% | -8.08% | -35.87% | -18.69% | -15.56% | -27.7% | 44.56% | 0.45% | 40.6% | 44.77% | 13.66% | 2906.64% | 38.25% | 31.71% | 18.19% |
| Operating Expenses | 10.9M | 11.07M | 10.69M | 17.88M | 10.38M | 12.48M | 12.91M | 15.56M | 11.96M | 11.46M | 13.9M | 18.39M | 21.3M | 24.16M | 19.84M | 29.78M | 66.11M | 23.59M | 40.16M | 35.37M |
| OpEx % of Revenue | 87.84% | 72.98% | 76.97% | 118.12% | 56.28% | 76.94% | 77.92% | 86.54% | 85.26% | 61.11% | 78.04% | 59.86% | 93.7% | 91.94% | 71.74% | 108.5% | 273.18% | 102.02% | 183.38% | 150.63% |
| Selling, General & Admin | 10.9M | 11.07M | 10.25M | 8.48M | 9.3M | 9.72M | 10.78M | 11.09M | 10.18M | 10.02M | 12.39M | 14.1M | 19.98M | 18.58M | 17.42M | 17.39M | 17.36M | 17.61M | 17.51M | 20.73M |
| SG&A % of Revenue | 87.84% | 72.98% | 73.78% | 56.01% | 50.42% | 59.93% | 65.07% | 61.68% | 72.61% | 53.44% | 69.52% | 45.86% | 87.89% | 70.7% | 63% | 63.37% | 71.73% | 76.16% | 79.98% | 88.29% |
| Research & Development | 0 | 0 | 0 | 216K | 162K | 522K | 426K | 1.04M | 611K | 521K | 595K | 465K | 856K | 1.71M | 1.06M | 3.25M | 3.28M | 4.47M | 1.65M | 4.76M |
| R&D % of Revenue | - | - | - | 1.43% | 0.88% | 3.22% | 2.57% | 5.81% | 4.36% | 2.78% | 3.34% | 1.51% | 3.77% | 6.51% | 3.85% | 11.85% | 13.56% | 19.35% | 7.54% | 20.29% |
| Other Operating Expenses | 0 | 0 | 444K | 1000K | 920K | 1000K | 1000K | 1000K | 1000K | 918K | 924K | 1000K | 464K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | -4.06M | -1.97M | -1.5M | -7.62M | 2.42M | -1.7M | -930K | -3.65M | -1.6M | 3.15M | -867K | 169K | -8.56M | -6.87M | -1.81M | -16.94M | -53.42M | -11.29M | -27.7M | -24.07M |
| Operating Margin % | -32.75% | -12.99% | -10.83% | -50.37% | 13.12% | -10.45% | -5.61% | -20.3% | -11.39% | 16.78% | -4.87% | 0.55% | -37.65% | -26.13% | -6.54% | -61.72% | -220.76% | -48.84% | -126.5% | -102.51% |
| Operating Income Growth % | -267.86% | -16.22% | -61.72% | -108.85% | 251.6% | -153.88% | -7.27% | -2259.76% | 81.34% | 145.81% | 52.05% | 101% | 83.98% | 39.19% | 93.47% | 29.63% | -108.14% | -102.58% | -678.72% | -262.8% |
| EBITDA | -2.94M | -1.08M | -701K | -6.33M | 3.74M | -522K | 497K | -1.71M | -64K | 4.94M | 976K | 2.29M | -6.37M | -4.66M | 493K | -14.72M | -50.85M | -8.62M | -25.02M | -20.75M |
| EBITDA Margin % | -23.71% | -7.15% | -5.05% | -41.82% | 20.26% | -3.22% | 3% | -9.49% | -0.46% | 26.33% | 5.48% | 7.44% | -28% | -17.74% | 1.78% | -53.63% | -210.12% | -37.27% | -114.27% | -88.36% |
| EBITDA Growth % | -178.73% | -107.85% | -241.05% | -270.98% | 5940.63% | -110.57% | -49.08% | -174.66% | 98.99% | 205.9% | 97.97% | 115.52% | 87.48% | 45.91% | 101.97% | 29.06% | -114.61% | -132.63% | -1544.02% | -341.35% |
| D&A (Non-Cash Add-back) | 1.12M | 885K | 803K | 1.29M | 1.32M | 1.17M | 1.43M | 1.94M | 1.53M | 1.79M | 1.84M | 2.12M | 2.19M | 2.21M | 2.3M | 2.22M | 2.57M | 2.67M | 2.68M | 3.32M |
| EBIT | -4.06M | -10.02M | 2.48M | -18.71M | 4.72M | 1.46M | 2.49M | -7.92M | -510K | 2.67M | -6.19M | 2.81M | -9.29M | -4.19M | -1.65M | -9.1M | -9.46M | -11.29M | -8.25M | -15.45M |
| Net Interest Income | -436K | -560K | -516K | -730K | -900K | -1.08M | -994K | -4.79M | -1.26M | -1.27M | -1.28M | 0 | 0 | -2.5M | -1.36M | -20.36M | -87.18M | -534K | -39.38M | -14.65M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 436K | 560K | 516K | 730K | 900K | 1.08M | 994K | 4.79M | 1.26M | 1.27M | 1.28M | 0 | 0 | 2.5M | 1.36M | 20.36M | 87.18M | 534K | 39.38M | 14.65M |
| Other Income/Expense | -1.54M | -8.61M | 3.47M | -11.82M | 1.4M | 2.08M | 2.43M | -272K | -170K | -1.75M | -6.61M | -2.63M | 1.36M | 175K | 1.11M | 851K | 130K | -257K | -259K | 5.33M |
| Pretax Income | -5.61M | -10.58M | 1.97M | -19.44M | 3.82M | 382K | 1.5M | -3.92M | -1.77M | 1.4M | -7.47M | -2.46M | -7.2M | -6.69M | -701K | -16.09M | -53.29M | -11.55M | -27.96M | -18.74M |
| Pretax Margin % | -45.19% | -69.79% | 14.15% | -128.46% | 20.69% | 2.35% | 9.04% | -21.82% | -12.6% | 7.46% | -41.94% | -7.99% | -31.67% | -25.47% | -2.53% | -58.62% | -220.22% | -49.95% | -127.68% | -79.8% |
| Income Tax | 10K | 0 | 0 | 437K | -122K | -283K | 405K | 695K | 521K | 780K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3K | -107K | 259K |
| Effective Tax Rate % | -0.18% | 0% | 0% | -2.25% | -3.2% | -74.08% | 27.04% | -17.72% | -29.49% | 55.75% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.03% | 0.38% | -1.38% |
| Net Income | -5.62M | -10.58M | 1.97M | -19.82M | 3.99M | 788K | 1.47M | -4.62M | -2.89M | -220K | -8.12M | -2.46M | -7.2M | -6.69M | -701K | -16.09M | -53.29M | -11.55M | -27.85M | -19M |
| Net Margin % | -45.27% | -69.79% | 14.15% | -130.94% | 21.65% | 4.86% | 8.89% | -25.68% | -20.58% | -1.17% | -45.57% | -7.99% | -31.67% | -25.47% | -2.53% | -58.62% | -220.22% | -49.94% | -127.19% | -80.9% |
| Net Income Growth % | -240.66% | -1443.15% | 33.31% | -329.24% | 238.34% | 458.18% | 118.15% | -87.91% | 59.9% | 96.71% | -1058.35% | 84.73% | 86.49% | 42.04% | 97.48% | 15.31% | -109.31% | -21.24% | -546.8% | -503.99% |
| Net Income (Continuing) | -5.62M | -10.58M | 1.97M | -19.88M | 3.94M | 665K | 1.09M | -4.62M | -2.29M | 619K | -7.47M | -2.46M | -7.2M | -6.69M | -701K | -16.09M | -53.29M | -11.55M | -27.85M | -19M |
| Discontinued Operations | 0 | 0 | 0 | 62K | 54K | 123K | 381K | 0 | -599K | -839K | -647K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.53 | -1.05 | -0.08 | -2.92 | 0.21 | -0.26 | 0.16 | -0.83 | -0.52 | -0.04 | -1.48 | -0.59 | -1.93 | -2.15 | -0.28 | -8.95 | -35.90 | -8.74 | -435.20 | -16.20 |
| EPS Growth % | -352.38% | -303.85% | -148.31% | -251.81% | 140.38% | -551.63% | 110.81% | -40.68% | 73.06% | 98.14% | -428.57% | 93.41% | 94.62% | 75.4% | 99.94% | 44.75% | -27.3% | 39.31% | -6117.14% | -189.29% |
| EPS (Basic) | -0.53 | -1.05 | 0.21 | -2.92 | 0.65 | 0.02 | 0.20 | -0.83 | -0.52 | -0.04 | -1.48 | -0.59 | -1.93 | -2.15 | -0.28 | -8.95 | -35.90 | -8.74 | -435.20 | -16.20 |
| Diluted Shares Outstanding | 10.51M | 10.04M | 19.48M | 6.79M | 8.2M | 8.49M | 9.1M | 5.54M | 5.53M | 5.52M | 5.48M | 4.06M | 3.73M | 3.11M | 2.52M | 1.8M | 1.48M | 1.32M | 1.32M | 1.18M |
| Basic Shares Outstanding | 10.51M | 10.04M | 9.44M | 6.79M | 6.13M | 6.13M | 7.37M | 5.54M | 5.53M | 5.52M | 5.48M | 4.06M | 3.73M | 3.11M | 2.52M | 1.8M | 1.48M | 1.32M | 1.32M | 1.18M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |